Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ Schlussglocke USA: American Eagle Outfitters und Ciena bullenstark (Der Aktionaer) +++ CIENA Aktie +4,45%

GLOBUS MEDICAL Aktie

 >GLOBUS MEDICAL Aktienkurs 
51.5 EUR    +2.0%    (Tradegate)
Ask: 52 EUR / 400 Stück
Bid: 51.5 EUR / 400 Stück
Tagesumsatz: 39 Stück
Realtime Kurs von 7:30 bis 22 Uhr!
GLOBUS MED Aktie über LYNX handeln
>GLOBUS MEDICAL Performance
1 Woche: -5,2%
1 Monat: +12,7%
3 Monate: -4,3%
6 Monate: -34,3%
1 Jahr: -22,7%
laufendes Jahr: -36,8%
>GLOBUS MEDICAL Aktie
Name:  GLOBUS MED.A NEW DL -,001
Land:  USA
Sektor:  Gesundheit
ISIN/ Wkn:  US3795772082 / A1J2LY
Symbol/ Ticker:  GM0N (Frankfurt) / GMED (NYSE)
Kürzel:  FRA:GM0N, ETR:GM0N, GM0N:GR, NYSE:GMED
Index:  -
Webseite:  http://www.globusmedical...
Profil:  Globus Medical Inc. is a leading medical device co..
>Volltext..
Marktkapitalisierung:  6936.7 Mio. EUR
Unternehmenswert:  6845.18 Mio. EUR
Umsatz:  2252.17 Mio. EUR
EBITDA:  544.5 Mio. EUR
Nettogewinn:  305.82 Mio. EUR
Gewinn je Aktie:  2.25 EUR
Schulden:  104.11 Mio. EUR
Liquide Mittel:  196.75 Mio. EUR
Operativer Cashflow:  573.8 Mio. EUR
Bargeldquote:  0.54
Umsatzwachstum:  6.78%
Gewinnwachstum:  697.26%
Dividende je Aktie:  -
Dividendenrendite:  -
Dividendenschätzung:  -
Insiderhandel:  -
Suchwörter:  GLOBUS MEDICAL, GLOBUS MED
Letzte Datenerhebung:  04.09.25
>GLOBUS MED Kennzahlen
Aktien/ Unternehmen:
Aktien: 112.62 Mio. St.
Frei handelbar: 99.29%
Rückkaufquote: 1.33%
Mitarbeiter: 5300
Umsatz/Mitarb.: 0.41 Mio. EUR
Analysten:
Analystenrating: Buy
Kursziel: 40.44%
Bewertung:
KGV: 22.96
KGV lG: 18.31
KUV: 3.11
KBV: 1.87
PEG-Ratio: 0.03
EV/EBITDA: 12.57
Rentabilität:
Bruttomarge: 58.23%
Gewinnmarge: 13.58%
Operative Marge: 13.83%
Managementeffizenz:
Gesamtkaprendite: 7.17%
Eigenkaprendite: 8.62%
>GLOBUS MED Peer Group

Es sind 601 Aktien bekannt.
 
04.09.25 - 19:45
Should You Hold Onto Globus Medical Stock in Your Portfolio for Now? (Zacks)
 
GMED rides strong musculoskeletal demand and new launches, but faces currency headwinds and fierce competition....
29.08.25 - 17:12
Globus Medical wins favorable jury verdict in patent dispute with Life Spine (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
28.08.25 - 22:33
Globus Medical, Inc. Secures Jury Verdict in Delaware Patent Litigation Against Life Spine, Inc. (GlobeNewswire EN)
 
AUDUBON, Pa., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, announced that a Delaware jury has returned a verdict in favor of Globus in its patent infringement litigation against Life Spine, Inc....
13.08.25 - 16:00
Globus Medical Stock Up on Q2 Earnings & Revenue Beat, Margins Expand (Zacks)
 
GMED posts strong Q2 with earnings and revenues, boosted by the Nevro acquisition and expanded margins....
08.08.25 - 21:09
Globus Medical reaffirms $2.8B–$2.9B 2025 sales outlook as integration advances and U.S. Spine momentum builds (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
08.08.25 - 02:30
Globus Medical (GMED) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates (Zacks)
 
Although the revenue and EPS for Globus Medical (GMED) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers....
08.08.25 - 01:00
Globus Medical (GMED) Q2 Revenue Up 18% (Fool)
 
Um den gesamten Artikel unter fool.com zu lesen, klicken Sie bitte auf die Überschrift...
07.08.25 - 22:18
Globus Medical Reports Second Quarter 2025 Results (GlobeNewswire EN)
 
AUDUBON, Pa., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial results for the quarter ended June 30, 2025....
21.07.25 - 14:51
Globus Medical appoints Keith Pfeil as CEO (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
21.07.25 - 14:03
Globus Medical Announces Leadership Transitions and Preliminary Second Quarter 2025 Sales Results (GlobeNewswire EN)
 
AUDUBON, Pa., July 21, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announced that Keith Pfeil, Executive Vice President, Chief Operating Officer and Chief Financial Officer, has been appointed President and Chief Executive Officer effective July 18, 2025. Daniel Scavilla has resigned as President and Chief Executive Officer effective July 18, 2025, in order to pursue another opportunity. Additionally, Kyle Kline, Senior Vice President of Finance, has been appointed Senior Vice President and Chief Financial Officer....
17.07.25 - 22:33
Globus Medical Schedules Second Quarter Earnings Release and Conference Call (GlobeNewswire EN)
 
AUDUBON, Pa., July 17, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal technology company, will announce its financial results for the second quarter ended June 30, 2025 after the market close on Thursday, August 7, 2025. A copy of the release will be available on the Globus Medical website at www.investors.globusmedical.com....
15.07.25 - 22:18
Globus Medical Introduces DuraPro™ with Navigation, a Next-Generation, Oscillating System Designed to Safeguard Delicate Tissue (GlobeNewswire EN)
 
AUDUBON, Pa., July 15, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced the expanded Excelsius™ navigation capabilities of its next-generation oscillating system, DuraPro™, as the latest addition to the Power Portfolio, designed to advance procedural workflows through safety features and efficiency....
15.05.25 - 22:42
Globus Medical announces share buyback program of up to $500M (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
15.05.25 - 22:33
Globus Medical Announces $500 Million Share Repurchase Program (GlobeNewswire EN)
 
AUDUBON, Pa., May 15, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced that its Board of Directors has authorized a share repurchase program of up to $500 million of the Company's outstanding common stock....
09.05.25 - 04:36
Globus medical outlines $2.8B-$2.9B 2025 revenue guidance amid Nevro integration (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
09.05.25 - 01:45
Globus Medical (GMED) Reports Q1 Earnings: What Key Metrics Have to Say (Zacks)
 
The headline numbers for Globus Medical (GMED) give insight into how the company performed in the quarter ended March 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals....
09.05.25 - 01:00
Globus Medical (GMED) Lags Q1 Earnings and Revenue Estimates (Zacks)
 
Globus Medical (GMED) delivered earnings and revenue surprises of -8.11% and 4.81%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?...
08.05.25 - 22:18
Globus Medical Reports First Quarter 2025 Results (GlobeNewswire EN)
 
AUDUBON, Pa., May 08, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial results for the quarter ended March 31, 2025....
07.05.25 - 18:48
Globus Medical Q1 2025 Earnings Preview (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
05.05.25 - 16:45
Gear Up for Globus Medical (GMED) Q1 Earnings: Wall Street Estimates for Key Metrics (Zacks)
 
Beyond analysts' top -and-bottom-line estimates for Globus Medical (GMED), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended March 2025....
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Ich möchte Österreich gerne zu einer Wall Street des Wissens machen. - Dr. Wolfgang Schüssel
Partner:    >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!